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Microarray is a powerful tool to compare the gene expression of different tumour specimens and cell lines simultaneously and
quantitatively. To get a better insight into genes that are involved in uveal melanoma tumorigenesis, we compared the gene
expression profiles of 12 different uveal melanoma cell lines with three melanocyte cell cultures obtained from healthy donor eyes.
Gene expression profiles were obtained by nylon filter arrays, containing 1176 gene spots related to cancer development. The
expression levels of selected genes were validated on cell lines and primary uveal melanomas by real time RT–PCR, and were
subsequently included in cluster analysis. Four candidate tumour markers, Laminin Receptor 1, Endothelin 2, Von Hippel Lindau
Binding protein 1 and Cullin 2, have been selected from genes that were differentially expressed in the uveal melanoma cell lines
compared to the normal uveal melanocytes. In primary uveal melanomas, these four markers could discriminate between two classes
of uveal melanoma, which may be indicative of a differential disease process.
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Up- and downregulated genes can be important determinants of
tumour development. To understand the biological behaviour of
tumour growth and progression, it is important to know how genes
are expressed in malignancies, compared to normal tissue.
Uveal melanoma is the most common primary intraocular
tumour of the eye in adults. The incidence ranges from six to eight
cases per one million subjects per year among Caucasians.
Approximately, 50% of patients with large uveal melanoma die
from metastases (Diener-West et al, 1992).
The well-known prognostic parameters for uveal melanoma are
clinico-histopathological parameters cell type, tumour diameter,
tumour localisation, mitotic rate and the presence of vascular
networks (Mooy and de Jong, 1996). Other defined factors are, for
instance, the expression of the epidermal growth factor receptor
(Hurks et al, 2000) and the reduced CDKN2A expression caused by
promoter hypermethylation (van der Velden et al, 2001). In spite
of these markers, metastases can still not be detected in an early
stage. The mortality rates, after metastasis has occurred, are very
high and hardly any treatment is effective for uveal melanoma
metastases. Therefore, better insight into tumour progression and
tumour dissemination is still of utmost importance.
Information regarding genes that are involved in the tumour
growth of uveal melanoma and in the development of metastases is
frequently derived from studies that relate biological parameters of
tumour progression to prognostic outcome. For instance, loss of
chromosome 3 and gain of the q arm of chromosome 8 are
significantly associated with poor survival and loss of 1p is a
specific hallmark of primary uveal melanoma metastases (White
et al, 1998; Aalto et al, 2001).
Recently, cDNA microarray studies have become a powerful tool
to detect differences in gene expression in different kinds of
tumours (Ross et al, 2000), and have subsequently demonstrated
that expression profiling can serve as a prognostic tool (Alizadeh
et al, 2001; van de Vijver et al, 2002).
In this study, we used filter arrays with more than a thousand
cDNAs related to cancer development, to reveal genes that are
differentially expressed in uveal melanoma cell lines compared to
cultured normal human melanocytes. In order to validate potential
progression markers, real-time quantitative RT–PCR analysis on
differentially expressed genes was used in cell lines and in fresh
frozen primary uveal melanoma specimens.
An important role in uveal melanoma development is now
suggested for Laminin Receptor 1 (LAMR1), Endothelin 2 (ET2),
Von Hippel Lindau Binding Protein 1 (VBP1) and Cullin 2 (CUL2)
genes, since their expression levels discriminate between two
classes of uveal melanoma.
MATERIALS AND METHODS
Cell lines and tumour characteristics
A total of 15 cell lines were included in this study. Nine cell lines
were derived from primary choroidal uveal melanomas (Mel202,
Mel285, Mel270, Mel290, 92.1, 92.2, OCM1, OCM3 and OCM8),
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(Omm1.3 and Omm1.5 are liver metastases from Mel270, and
OMM1 was obtained from a subcutaneous metastasis) (Luyten
et al, 1996). The cell lines OCM1, OCM3 and OCM8 were kindly
provided by Dr Kan-Mitchell (Kan-Mitchell et al, 1989). Cell lines
Mel202, Mel285, Mel290, Mel270 and the two cell lines derived
from liver metastases were provided by Professor BR Ksander
(Schepens Eye Institute, Boston, MA, USA). Cell lines 92.1 and 92.2
were derived from the same primary tumour and were established
in our own laboratory (Waard-Siebinga et al, 1995).
Three melanocyte cell cultures were grown from three normal
human donor eyes of two different individuals (Melcyt1A,
Melcyt1B and Melcyt2). After the corneae of these eyes were
prepared for donor purposes, the remaining tissues were kindly
provided by the Netherlands Ophthalmic Research Institute (Eye
Bank, IOI, Amsterdam). The freshly obtained eyes were rinsed with
PBS and superfluous tissue was removed. The eye was cut into two
parts, and the part containing the iris and lens was discarded. The
vitreous body and retina of the remaining part were removed.
After incubation in 0.125% trypsin (Gibco, Paisley, Scotland) in
0.02% EDTA during 1h at 371C the retinal pigment epithelium was
removed. The choroid was peeled off the sclera and incubated in
0.25% trypsin during 18h at 41C. After the addition of culture
medium, the cells were collected by centrifugation and plated.
Geneticin (Gibco) was added to the culture medium to a final
concentration of 100mgml
 1 to eliminate contaminating cells, like
fibroblasts. The cell cultures were characterised by immunohis-
tochemistry for S100 and NKI/beteb (Vennegoor et al, 1988).
The melanoma cell lines were cultured in RPMI 1640 (Gibco)
medium and supplemented with 3mML -glutamine (Gibco), 2%
penicillin/streptomycin and 10% FBS (Hyclone, UT). The three
melanocyte cell lines were grown in F12 medium (Gibco),
following the directions of Hu et al (1993). All cell cultures were
incubated at 371C in a humidified 5% CO2 atmosphere.
The fresh frozen uveal melanoma samples were derived from 19
different primary choroidal melanomas. The research protocol
followed the Tenets of the Declaration of Helsinki. Histopatholo-
gical analysis was performed by an ocular pathologist. Table 1
presents the clinical and pathological characteristics of the fresh
frozen uveal melanoma samples. We are limited in survival
analysis due to follow-up data of three years.
Microarray cDNA hybridisation and analysis
Cells from early passages were grown to subconfluency and the
total RNA of each cell line was isolated with the RNeasy kit,
following the directions of the manufacturer (Qiagen, Hilden,
Germany). Biotin-labelled oligo-dT and streptavidin-labelled
magnetic beads were used to isolate the mRNA from the total
RNA. Probe synthesis and hybridisation were performed
according to the protocol of the manufacturer of the Human
Cancer Atlas 1.2 filters (Clontech, Palo Alto, CA, USA). The cDNA
was labelled with a
32P-dATP. Each cell line was hybridised to two
separate filters in order to obtain a technical replicate. In this
study, the melanocyte cell lines were used as references and
controls. Cell lines Melcyt1A and Melcyt1B are derived from two
different eyes of one person in order to create an internal
biological control.
A nylon Human Cancer Atlas filter consists of 1176 different
cDNA spots designed to reflect molecular pathways in oncogenesis
and several house-keeping genes.
To analyse and quantify the spots obtained by the phosphor-
imager scans, we used the GenePix
s Pro analyzing computer
program (Axon Instruments, Inc., Union City, CA, USA). Each cell
line was normalised to the value of the uveal melanocyte,
Melcyt1A. The obtained ratios were analysed by a hierarchical
clustering method (Cluster) to compare the expression data. In this
type of clustering method, the data points are forced into a strict
hierarchy of nested subsets, resulting in a phylogenetic tree with
branch lengths that indicate the degree of similarity between the
samples (Tamayo et al, 1999). The data obtained by these analysis
programs were visualised by TreeView (Eisen et al, 1998; Tavazoie
et al, 1999).
Real-time quantitative RT–PCR analysis
To validate the results of the microarray, we performed real-time
quantitative RT–PCR analyses on the cell lines and primary frozen
tumour samples (Heid et al, 1996). The same method and protocol
of the RNeasy kit was applied to isolate total RNA from sections of
the fresh frozen melanoma samples. In all 1mg of total RNA of all
cell lines and tumour samples was reverse-transcribed with M-
MLV reverse transcriptase (Gibco-BRL, Eggenstein, Germany) in a
Table 1 Clinical and pathological characteristics of 19 fresh frozen primary uveal melanoma samples
Tumour
sample Cell type
Prominence
(mm)
Diameter
(mm) Pigment Mitosis
a
Intravascular
ingrowth
Vascular
loops Metastases Location
1 Epithelioid 8 14 450% 3 Yes Yes No Chor
b
2 Spindle 10 12 450% 2 No Yes No Chor
3 Mixed 7 15 450% 3 No Yes Yes Cbd-chor
c
4 Spindle 11 11 o50% 5 No Yes No Cbd-chor
5 Mixed 9 14 450% 5 Yes No No Cbd-chor
6 Mixed 12 17 o50% 8 No Yes No Chor
7 Spindle 9 16 o50% 2 No Yes No Cbd-chor
8 Mixed 8 14 Severe NA
d No Yes No Chor
9 Mixed 8 17 o50% 5 Yes Yes No Cbd-chor
10 Mixed 9 16 450% 4 No Yes No Cbd-chor
11 Mixed 13 20 450% 7 No Yes No Cbd
12 Spindle 11 20 450% 20 No Yes No Cbd
13 Mixed 13 18 50% 21 Yes Yes No Cbd-chor
14 Mixed 13 20 o50% 20 No NA No Chor
15 Mixed 6 18 450% 1 No No No Cbd-chor
16 Mixed 11 20 50% 21 Yes No No Cbd-chor
17 Mixed 8 21 o50% 6 No Yes No Chor
18 Mixed 8 20 Severe 9 Yes Yes No Cbd-chor
19 Mixed 12 20 50% 10 No Yes No Cbd-chor
aNumber of mitoses per 15 fields of microscopic examination at a magnification of  320.
bChor¼choroidea.
cCbd¼ciliar body.
dNA¼not available.
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presence of random hexamere primers at a temperature of 421C for
50min (Promega, San Louis Obispo, CA, USA). We applied the
real-time PCR method using the SYBR
s Green PCR Master Mix as
supplied by the manufacturer (PE Applied Biosystems, Inc., Foster
City, CA, USA). The SYBR
s Green I dye detects double-stranded
DNA, not requiring specific probes. The Mix includes a passive
reference, which is required for signal normalisation. To minimise
nonspecific product formation, the reaction Master Mix contains
the enzyme AmpliTaq Gold
s DNA polymerase. An ABI PRISM
7700 Sequence Detection System monitors the fluorescence signal
during the PCR reaction. It registers the number of cycles at which
the signal reaches a certain threshold level. The differences
between the threshold value of the target transcripts and the
endogenous references are used to calculate the relative expres-
sion.
The primers for the four genes under study, ET2, LAMR1, VBP1
and CUL2, and the two endogenous controls U1A and RPS11 were
designed with the Primer Express software (PE Applied Biosys-
tems) (Table 2). All reactions were repeated twice with two
different endogenous controls to ensure reproducibility of the
results. For comparing the efficiency of amplification of the gene
targets and the controls, a serial dilution was made of each
different cDNA sample. All experiments revealed a nearly optimal
efficiency close to 100%.
Statistical analysis
Correlations between clinico-histopathological parameters and the
expression level of the four genes were determined using the
Pearson correlation test.
RESULTS
Microarray analysis
In this study, the expression profile of 12 different human uveal
melanoma cell lines was compared to three uveal melanocyte
cultures. The mRNA of all cell cultures was hybridised in replicate
to filter arrays containing 1176 cDNAs related to tumorigenesis.
The duplicate experiments revealed nearly identical hybridisations
that clearly showed the fingerprints of each cell line. Nevertheless,
a small percentage of genes were differentially expressed between
the duplicates. Only the few genes with opposite results were
discarded from analysis. The gene expression of each cell line was
normalised to one melanocyte cell culture (Melcyt1A). A total of
449 genes revealed no expression in all 15 cell lines, that is, their
expression was not significantly higher than the local background.
Only 52 genes were expressed in all cell cultures, that is,
melanomas and melanocytes. In total, 54 genes were expressed
only in melanoma cell lines and 187 genes exclusively in the
melanocytes.
In at least eight melanoma cell lines, 29 genes were expressed
that were not expressed in any of the three normal melanocyte
cultures (not significantly higher than the local background).
Fifteen of these genes were highly differentially expressed, that is,
we considered a gene to be highly expressed if the expression ratio
of an uveal melanoma cell line was at least 1.5-fold higher
compared to the normal uveal melanocytes Melcyt 1B and Melcyt 2
(Table 3). From this list, we selected four genes revealing the
highest percentage of uveal melanoma cell lines displaying an
increase in the expression ratio compared to the controls (Table 3).
Furthermore, the common origin of the primary tumour cell line
Mel 270 and its two liver metastatic cell lines Omm1.3 and Omm1.5
Table 2 Primer sequences of the genes validated in the real-time quantitative RT–PCR assays
Primer Primer (forward) Primer (reverse)
U1A 50-gca gct tat gcc agg aca gat-30 50-ttg gtg agg aac aag atg tga ttc-30
RPS11 50-aag cag ccg acc atc ttt ca-30 50-cgg gag ctt ctc ctt gcc-30
ET2 50-tgg agg ctg cgt cct ga-30 50-ctg agg cat gcg tgt tcg t-30
LAMR1 50-cca ctg gag cca ctc caa tt-30 50-ggc tgc ctg gat ctg gtt agt-30
VBP-1 50-gac cag att ctt gct ggc aga t-30 50-agc ccc caa cca cag aca c-30
CUL-2 50-gtt cgt atc atg aaa gca cga aaa-30 50-tta aac cta gct ctt gac tgg cta atc-30
Table 3 Microarray results: selection of genes revealing high differential expression ratios in uveal melanoma cell lines normalised to uveal melanocyte 1A
(Melcyt1A)
Name Melcyt1B Melcyt2 Mel270 Omm1.3 Omm1.5 Mel202 Mel285 Mel290 92.1 92.2 Ocm1 Ocm3 Ocm8 Omm1
LAMR1 0.87 1.11 3.62 6.66 4.72 2.15 2.40 2.28 7.24 6.33 6.30 3.04 3.21 4.47
ET2 1.18 1.39 26.68 34.92 42.63 1.18 0.92 1.34 3.67 3.47 50.11 8.32 4.02 36.48
CUL2 1.16 1.15 1.05 1.14 1.17 1.69 1.81 3.69 3.82 4.35 10.27 6.53 1.47 6.90
VBP1 1.09 1.42 0.89 0.94 1.01 2.19 3.52 9.64 6.52 4.75 3.87 3.23 2.02 2.64
RHOC 1.13 1.28 2.66 3.77 3.27 1.47 1.48 1.62 2.25 2.41 4.43 3.08 3.58 3.18
PKCI1 1.21 1.46 5.1 3.28 1.71 2.41 3.34 5.16 8.3 5.71 4.32 3.43 3.55 4.85
TIMP1 0.83 0.96 3.03 9.90 15.24 1.07 2.20 1.80 2.01 1.85 4.05 2.96 2.82 4.06
SOD1 0.89 1.06 2.21 0.84 0.65 1.94 3.30 2.48 5.40 5.73 3.16 1.91 2.94 2.01
HMGIY 0.89 0.78 3.93 1.95 0.81 1.62 2.92 1.18 2.47 2.04 2.27 1.35 1.52 1.79
RPS5 0.76 0.80 3.18 6.01 3.51 1.58 1.77 1.09 4.50 2.79 2.13 1.44 2.33 1.22
CCND1 0.89 1.06 1.39 0.85 1.07 2.35 3.52 1.69 2.37 1.84 2.12 3.40 3.35 1.69
IL13 1.19 1.17 5.19 2.70 2.92 1.22 0.99 0.93 3.01 4.08 177.83 17.15 6.01 24.37
EIF3-beta; EIF3B 0.99 0.73 2.71 1.15 1.06 2.80 2.87 1.55 1.85 5.01 1.60 1.27 1.83 1.14
ETV4; E1A-F 1.17 0.82 2.20 1.25 1.17 1.54 0.92 1.00 1.94 2.21 34.47 7.70 24.75 5.99
CDC37 homolog 0.99 0.92 2.91 1.38 1.16 2.01 2.05 1.39 3.81 4.35 2.98 1.56 1.53 1.44
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(Table 3). Hierarchical cluster analysis revealed their close
relationship in a phylogenetic cluster tree. The similarity could
be clearly recognised in the tree by the short branches reflecting
their degree of correlation. The latter was also apparent for cell
lines 92.1 and 92.2, both derived from the same primary tumour.
The genetic origin of these cell lines appears to be the major
determinant of expression, since the lines resemble each other
more than any of the other cell lines, indicating that these cell lines
have kept their identity during in vitro culturing and their
reliability as a model for tumour research. This importance of
genetics in gene expression was also demonstrated by Cheung et al
(2003).
Real-time quantitative PCR analysis
Cell lines ET2, LAMR1, VBP1 and CUL2 belong to the group of
genes exhibiting the most discriminating differential expression
ratio in uveal melanomas cell lines compared to the expression
ratio of the normal melanocytes (Table 3). We validated the
differential expression of these genes by real-time RT–PCR.
Similar expression of the two endogenous controls U1A (small
nuclear protein) and RPS11 (ribosomal protein) excluded possible
influences of regulation.
The absolute expression levels of the four genes were markedly
different. The average expression of CUL2 was 64 times higher
compared to the average expression level of ET2, VBP1 showed 512
times higher and LAMR1 4096 times higher than ET2.
Despite differences in absolute expression levels obtained by
filter array and real time RT–PCR, both assays separately
confirmed the importance of these genes.
Comparing the expression data between the filter array and the
real-time PCR, real time RT–PCR confirmed a high expression
level of ET2 in two of the 12 cell lines. The VBP1 gene revealed a
high expression in nine out of 12 cell lines vs seven out of 12 cell
lines in the PCR assay, with corresponding results between both
assays in the case of four cell lines (Mel285, Ocm3, Ocm8 and
92.1). The same trend was observed in the expression pattern of
CUL2; in the microarray eight out of 12 cell lines revealed a high
expression compared to normal melanocyte expression, whereas in
the PCR assay nine out of 12 cell lines fulfilled this criterion.
LAMR1 expression in the microarray was very consistent with
its expression measured by real-time PCR. In both assays we
observed low expression in the melanocytes and cell lines Ocm8,
Mel202 and Mel290, whereas the cell lines 92.1, Ocm1, Omm1 and
Omm1.3 revealed high expression levels. This is of great interest,
since two of these cell lines with a high expression level of LAMR1
are derived from metastases.
Fresh frozen primary uveal melanoma samples
In order to validate the candidate tumour markers obtained in cell
lines, we performed real-time quantitative PCR analysis on 19 fresh
frozen uveal melanoma samples.
The genes LAMR1 and especially ET2 revealed highly differ-
ential expression levels, whereas the expression levels of the genes
CUL2 and VBP1 were not markedly highly differential.
Cluster analysis of the real-time PCR results of the genes under
study revealed two distinct clusters in the primary tumour samples
(Figure 1). The first cluster was formed by eight samples revealing
a relatively high expression of the genes ET2, LAMR1, CUL2 and
VBP1. The relatively low expression levels of all these genes were
observed in a second cluster of 11 tumour samples.
Pearson test identified one significant correlation between gene
expression and histopathological parameters of the tumours; ET2,
LAMR1 and VBP1 were positively correlated with PAS-positive
loops (P¼0.005, 0.028 and 0.01, respectively).
We were not able to perform a solid survival analysis, since all
tumours were collected recently.
DISCUSSION
We used microarray technology and real-time RT–PCR to
compare gene expression profiles of uveal melanoma cell lines
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Figure 1 (A) Cluster figure (Treeview) of the real-time RT–PCR results
of fresh frozen uveal melanoma samples. Red indicates a relatively high
expression level and green indicates a relative low expression level. (B)
Column graphs presenting the relatively quantity of expression per gene.
The samples are set in the same order as in the cluster figure. The
differences in the relative expression levels between the two clusters of the
uveal melanoma samples are demonstrated in these graphs as well.
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yand normal melanocytes, in order to identify potential tumour
progression markers.
Based on the type and purpose of our array technique, we
validated a selection of four genes, that is, LAMR1, ET2, VBP1 and
CUL2, with high differential expression by quantitative real-time
RT–PCR. In addition, we performed real-time RT–PCR of these
four genes in a panel of primary uveal melanomas. Hierarchical
clustering of these data resulted in two distinct subgroups with
differences in the expression level.
Between the two assays, there is a difference in expression level
of the selected genes. The higher the average expression level, the
stronger the correlation with the microarray results. The filter
technique applied in this study was not able to detect genes with a
low expression level securely enough to obtain a valid estimate of
the expression differences; nevertheless, it appeared to be a useful
method to identify a combination of genes that might play a role in
uveal melanoma development.
The expression patterns of the genes VBP1 and CUL2 exhibited
a small overlap in both assays and revealed no elevated expression
levels in the primary tumour samples. Both genes are Von Hippel-
Lindau (VHL)-related genes. VHL regulates transcription elonga-
tion and is known to act as a tumour suppressor protein. CUL2 is a
member of the cullin family of proteins and binds to the VHL/
elongin B/elongin C complex (VBC). The members are believed to
target certain cellular proteins for ubiquitination and degradation
and are in some cases involved in cell cycle regulation (Pause et al,
1997; Clifford et al, 1999). VBP1 forms complexes with the VHL
gene product. VHL acts as a molecular chaperone that carries
VBP1 from perinuclear granules to the nucleus or cytoplasm
(Tsuchiya et al, 1996). In spite of the highly differential expression
ratios of these two genes in the microarray, the expression levels in
the primary uveal melanomas were not high. Nevertheless, they
seem to have a discriminating role in the primary uveal
melanomas.
The microarray data displayed differential expression of ET2 in
nine of the 12 cell lines. However, real-time PCR confirmed an
upregulated ET2 expression in only two of the 12 melanoma cell
lines. On the other hand, all 19 tumour samples revealed a high
expression of ET2. The validation of ET2 in the cell lines would not
consider this gene to be of importance for uveal melanoma
development. However, several studies provided abundant evi-
dence for ET2 in cancer development. The NCI60 Cancer
Microarray project described a high expression level of the
endothelin receptor type B (ENRB) in skin melanoma (Ross et al,
2000), and Demunter et al (2001) reported evidence for its role as a
tumour progression marker in this tumour type.
ENRB is a nonspecific receptor for all three isotypes of
endothelin: ET1, ET2 and ET3 (Arai et al, 1990; Sakurai et al,
1990). ET2 can act as a mitogen in many cancer systems, and ETs
in general stimulate melanocyte proliferation and differentiation
(Reid et al, 1996). Recently, Smith et al (2002) associated decreased
ENRB expression in large primary uveal melanoma with early
clinical metastasis and short survival. These results, together with
the high expression levels of ET2 in our tumour samples, might
support investigation of the expression of endothelin receptors and
their ligands in uveal melanoma.
LAMR1 revealed the most interesting results. Combining both
assays we observed at least a 2.5-fold higher LAMR1 expression
ratio in eight uveal melanoma cell lines (including all metastatic
cell lines Omm1.3, Omm1.5 and Omm1) compared to the basic
expression ratio of normal melanocytes. Furthermore, eight of the
19 primary tumour samples revealed relatively high expression
levels of LAMR1, including the only patient in whom metastases
had already developed. Interestingly, LAMR1 is significantly
correlated with the PAS-positive loops, containing laminin (Thies
et al, 2001). LAMR1 is known for its role in cancer proliferation,
invasion and metastasis (Satoh et al, 1992; Castronovo, 1993).
Hipfel et al (2000) observed a high expression of this laminin
receptor in skin melanoma but not in naevi and normal skin.
Despite the lack of survival data in our study, an interesting
relationship between the level of LAMR1 expression and metastatic
potential might be present, encouraging further exploration of the
role of LAMR1 in the development of uveal melanoma metastases.
Validation of the four genes on the primary melanoma samples
resulted in two distinct subgroups with specific expression
profiles. Besides LAMR1, the histopathologic parameter PAS-
positive loops revealed a significant association with the expres-
sion level of the genes ET2 and VBP1. The ability to form vascular
loops is an important prognostic parameter in uveal melanoma
metastases development (Folberg et al, 2001). Therefore, these two
clusters within these samples might have a prognostic value in
tumour dissemination.
In conclusion, filter microarray is a strong tool to compare the
gene expression profiles of cell lines of different origin, but careful
attention should be paid to the quantitative value of this filter
method in the case of genes with low expression levels. By dint of
this powerful technique, we identified discriminating fingerprints,
and subsequently defined tumour markers possibly involved in
uveal melanoma tumour development and progression, such as
ET2 and LAMR1.
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